Latest Lakefront Biotherapeutics News & Updates

See the latest news and media coverage for Lakefront Biotherapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Lakefront Biotherapeutics

Biotechnology acquisition and development firm

lakefrontbio.com
Headquarters
Mechelen, Belgium
Founded year
1999
Company type
Public company
Number of employees
50–200
Industry
Pharmaceuticals

Last updated

Latest news about Lakefront Biotherapeutics

In short: Lakefront Biotherapeutics rebranded from Galapagos, initiated a €50 million share buyback, and acquired Ouro Medicines with Gilead.

Company announcements

Lakefront Biotherapeutics

Lakefront appoints Eric Hedrick MD as Chief Medical Officer

He will lead clinical development and join the Management Committee, supporting the company's transformation after the Ouro Medicines acquisition.

Unlock all announcements with a

Media coverage

De Telegraaf

Offer for €0.49/week

The AEX expands the nice profit further around lunchtime. Especially frontrunner ASML provides support to continue the upward path. Arcelor lies there...

Yahoo Finance

Lakefront Announces Initiation of €50 Million Stock Repurchase Program

CET; regulated information - Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced the launch of a share repurchase program (the "Program"), under which the...

Unlock all articles with a

Never miss news about Lakefront Biotherapeutics

Track Lakefront Biotherapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.